{"id":196208,"date":"2021-03-07T13:43:20","date_gmt":"2021-03-07T10:43:20","guid":{"rendered":"https:\/\/en.buradabiliyorum.com\/oral-covid-treatment-yields-promising-trial-data-drugmakers\/"},"modified":"2021-03-07T13:43:20","modified_gmt":"2021-03-07T10:43:20","slug":"oral-covid-treatment-yields-promising-trial-data-drugmakers","status":"publish","type":"post","link":"https:\/\/buradabiliyorum.com\/en\/oral-covid-treatment-yields-promising-trial-data-drugmakers\/","title":{"rendered":"#Oral Covid treatment yields promising trial data: drugmakers"},"content":{"rendered":"<p>&#8220;<strong>#Oral Covid treatment yields promising trial data: drugmakers<\/strong>&#8221;<\/p>\n<div>\n<div class=\"article-gallery lightGallery\">\n<div data-thumb=\"https:\/\/scx1.b-cdn.net\/csz\/news\/tmb\/2021\/germanpharma.jpg\" data-src=\"https:\/\/scx2.b-cdn.net\/gfx\/news\/2021\/germanpharma.jpg\" data-sub-html=\"German pharmaceutical company Merck is trying to develop two orally administered drugs to fight Covid-19\">\n<figure class=\"article-img\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/scx1.b-cdn.net\/csz\/news\/800a\/2021\/germanpharma.jpg\" alt=\"German pharmaceutical company Merck is trying to develop two orally administered drugs to fight Covid-19\" title=\"German pharmaceutical company Merck is trying to develop two orally administered drugs to fight Covid-19\" width=\"800\" height=\"500\"\/><figcaption class=\"text-darken text-low-up text-truncate-js text-truncate mt-3\">\n                German pharmaceutical company Merck is trying to develop two orally administered drugs to fight Covid-19<br \/>\n            <\/figcaption><\/figure>\n<\/div>\n<\/div>\n<p>German pharmaceutical giant Merck and a US partner reported promising results Saturday in trials of a drug administered orally to fight COVID-19, saying it helps reduce patients&#8217; viral load.\n                                                <\/p>\n<p>                                                                                &#8220;At a time where there is unmet need for antiviral treatments against SARS-CoV-2, we are encouraged by these preliminary data,&#8221; said Wendy Painter, chief medical officer of the US firm, Ridgeback Biotherapeutics.<\/p>\n<p>In January, Merck halted work on two COVID vaccine candidates but has pressed on with research into two products to treat the disease, including a pill-based one called molnupiravir, which it has developed with Ridgeback Biotherapeutics. <\/p>\n<p>This drug caused a significant drop in patients&#8217; viral load after five days of treatment with it, Merck said at a meeting with infectious disease experts.<\/p>\n<p>This Phase 2a test\u2014drug trials have three stages before a product can be <a href=\"https:\/\/buradabiliyorum.com\/en\/category\/download-scripts-themes-apps\/\" data-internallinksmanager029f6b8e52c=\"9\" title=\"Download Scripts &amp; Themes &amp; Apps\" target=\"_blank\" rel=\"noopener\">app<\/a>roved\u2014was carried out among 202 non-hospitalized people with symptoms of COVID-19.<\/p>\n<p>There was no alert in terms of safety, and of four serious adverse events that were reported, none were considered to be related to taking this drug, Ridgeback said. <\/p>\n<p>Anti-viral oral drugs such as oseltamivir (Tamiflu) and zanamivir (Relenza) are sometimes prescribed for seasonal flu but researchers have yet to come up with something similar to fight the coronavirus.<\/p>\n<p>The findings of this study\u2014a quicker decrease in viral load among individuals with early-stage COVID-19 who are treated with molnupiravir\u2014are promising, said William Fischer, lead investigator of the study and a professor of medicine at the University of North Carolina.<\/p>\n<p>&#8220;If supported by additional studies, (they) could have important public health implications, particularly as the SARS-CoV-2 virus continues to spread and evolve globally,&#8221; Fischer added.<\/p>\n<p>Merck is also working on another oral COVID treatment called MK-711. <\/p>\n<p>Preliminary results from clinical trials with it show a more than 50 percent reduction in risk of death or respiratory trouble in patients hospitalized with moderate to severe COVID-19, the company said in January.\n                                                                                                                        <\/p>\n<hr\/>\n<div class=\"article-main__explore my-4 d-print-none\">\n<p>                                                                                        Merck ends development of two potential COVID-19 vaccines\n                                                                                    <\/p><\/div>\n<hr class=\"mb-4\"\/>\n<p class=\"article-main__note mt-4\">\n                                                \u00a9 2021 AFP<\/p>\n<p>                                        <!-- print only --><\/p>\n<div class=\"d-none d-print-block\">\n<p>                                                 <strong>Citation<\/strong>:<br \/>\n                                                 Oral Covid treatment yields promising trial data: drugmakers (2021, March  7)<br \/>\n                                                 retrieved  7 March 2021<br \/>\n                                                 from https:\/\/medicalxpress.com\/<a href=\"https:\/\/buradabiliyorum.com\/en\/category\/news\/\" data-internallinksmanager029f6b8e52c=\"2\" title=\"News\" target=\"_blank\" rel=\"noopener\">news<\/a>\/2021-03-oral-covid-treatment-yields-trial.html<\/p>\n<p>                                            This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no<br \/>\n                                            part may be reproduced without the written permission. The content is provided for information purposes only.<\/p><\/div>\n<\/p><\/div>\n<p><script id=\"facebook-jssdk\" async=\"\" src=\"https:\/\/connect.facebook.net\/en_US\/sdk.js\"><\/script><\/p>\n<blockquote><p><strong><span style=\"color: #ff6600;\">If you liked the article, do not forget to share it with your friends. Follow us on\u00a0<span style=\"color: #ff0000;\"><a style=\"color: #ff0000;\" href=\"https:\/\/news.google.com\/publications\/CAAqBwgKMLG0nwswvr63Aw\" target=\"_blank\" rel=\"nofollow noopener noreferrer\">Google News<\/a><\/span>\u00a0too, click on the star and choose us from your favorites.<\/span><\/strong><\/p><\/blockquote>\n<blockquote>\n<p style=\"text-align: center;\">For forums sites go to <span style=\"color: #ff9900;\"><a style=\"color: #ff9900;\" href=\"https:\/\/forum.buradabiliyorum.com\/\" target=\"_blank\" rel=\"noopener\">Forum.BuradaBiliyorum.Com<\/a><\/span><\/strong>\n<\/p><\/blockquote>\n<blockquote>\n<p style=\"text-align: center;\"><strong>If you want to read more Like this articles, you can visit our <span style=\"color: #ff9900;\"><a style=\"color: #ff9900;\" href=\"https:\/\/en.buradabiliyorum.com\/science\/\" target=\"_blank\" rel=\"noopener\">Science category.<\/a><\/span><\/strong><\/p>\n<\/blockquote>\n<p><span style=\"color: black;\"><a style=\"color: #ff9900;\" href=\"https:\/\/medicalxpress.com\/news\/2021-03-oral-covid-treatment-yields-trial.html\" target=\"_blank\" rel=\"noopener\">Source<\/a><\/span><\/p>\n","protected":false},"excerpt":{"rendered":"<p>&#8220;#Oral Covid treatment yields promising trial data: drugmakers&#8221; German pharmaceutical company Merck is trying to develop two orally administered drugs to fight Covid-19 German pharmaceutical giant Merck and a US partner reported promising results Saturday in trials of a drug administered orally to fight COVID-19, saying it helps reduce patients&#8217; viral load. &#8220;At a time&#8230;<\/p>\n","protected":false},"author":1,"featured_media":196209,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"fifu_image_url":"https:\/\/scx2.b-cdn.net\/gfx\/news\/2021\/germanpharma.jpg","fifu_image_alt":"","footnotes":""},"categories":[16],"tags":[],"class_list":["post-196208","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-sciencee"],"_links":{"self":[{"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/posts\/196208","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/comments?post=196208"}],"version-history":[{"count":0,"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/posts\/196208\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/media\/196209"}],"wp:attachment":[{"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/media?parent=196208"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/categories?post=196208"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/tags?post=196208"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}